Pricing Log in Create free account

Artelo Biosciences, Inc. (ARTL) vs Valion Bio, Inc. (VBIO)

Artelo Biosciences, Inc. and Valion Bio, Inc. are both Biotechnology companies. Artelo Biosciences, Inc. and Valion Bio, Inc. are of similar size ($1.2M and $1.1M). Across the 11 metrics below, Artelo Biosciences, Inc. leads on 6 and Valion Bio, Inc. on 5.

Valuation

Metric ARTL VBIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.14 9.40
P/B 0.12 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.33 n/m 0.66
EV/Sales n/m 11.09 9.02
Earnings yield (10,336.94%) (40,026.00%) (32.88%)
Free cash flow yield (2,139.52%) (22,510.36%) (23.13%)

Profitability

Metric ARTL VBIO Biotechnology median
Gross margin 0.00% (58.09%) 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (705.71%) (489.30%) (51.96%)
Return on assets (234.30%) (104.96%) (46.06%)
Return on invested capital (865.85%) (61.01%) 0.00%

Growth

Metric ARTL VBIO Biotechnology median
Revenue growth (TTM) — (49.63%) 6.76%
EPS growth (last fiscal year) 31.57% 60.16% 29.88%
Revenue growth, 5-year CAGR — 13.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL VBIO Biotechnology median
Debt to equity 0.00 0.62 0.00
Current ratio 3.00 1.11 4.97
Net debt to EBITDA 0.05 0.79 1.01

Dividend

Metric ARTL VBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARTL VBIO Biotechnology median
Market cap 1.16m 1.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack